courses

CATEGORY

Department of Hematology

Department of Hematology

Staff

Educational Priorities and Overview

The Department of Hematology integrates molecular biology, immunology, and cell biology with clinical practice encompassing diagnosis, pharmacotherapy, cellular therapy, hematopoietic cell transplantation, and supportive care. Guided by Kawasaki Medical University’s founding principles, we educate physicians by combining clinical competence, a holistic understanding of patients, and scientific inquiry.

The undergraduate education program systematically covers hematopoiesis, blood cell morphology, anemia, bleeding disorders, hematologic malignancies, and transplantation. Interactive, case-based teaching connects clinical reasoning with current evidence. During clinical clerkships, students join patient-care teams, integrate clinical and laboratory findings, formulate diagnostic and therapeutic plans, and develop communication, decision-making, multidisciplinary teamwork, and professional ethics. Structured postgraduate training supports progression from broad competence in internal medicine to hematology specialization. Our graduate students receive mentoring in study design, experimental and biospecimen analysis, statistics, conference presentation, and publication.

Research Fields and Major Themes

Our research translates questions arising in clinical practice into improved diagnosis and treatment. Building on established work in red blood cell membrane disorders, hemolytic anemia, hematologic malignancies, and hematopoietic cell transplantation, we are expanding cancer immunotherapy, particularly CAR T-cell therapy and bispecific antibodies. Basic studies use patient-derived specimens, tumor cells, and animal models, while clinical studies integrate real-world data, biomarkers, and patient-reported outcomes.

The major themes of our research include:
  • Biomarkers and resistance mechanisms in immunotherapy
  • Next-generation therapies targeting the tumor microenvironment, T-cell function, and antigen loss
  • Molecular and clinical studies of hematologic malignancies
  • Red cell disorders; and complications
  • Cytopenias, infections, and quality of life after transplantation and cellular therapy